{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:08:38Z","timestamp":1790348918725,"version":"4.1.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T00:00:00Z","timestamp":1391472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087837","type":"journal-article","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T22:10:10Z","timestamp":1391551810000},"page":"e87837","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge"],"prefix":"10.1371","volume":"9","author":[{"given":"Marina","family":"De Filette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Soehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Ulbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Richner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sinigaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Barzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianna","family":"Lisziewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Lorincz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niek N.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.med.57.121304.131418","article-title":"West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States","volume":"57","author":"EB Hayes","year":"2006","journal-title":"Annu Rev Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-141-5-200409070-00010","article-title":"Clinical characteristics and functional outcomes of West Nile Fever","volume":"141","author":"JT Watson","year":"2004","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Sampathkumar P (2003) West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention. Mayo Clin Proc 78: 1137\u20131143; quiz 1144.","DOI":"10.4065\/78.9.1137"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"RS Lanciotti","year":"1999","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1086\/521911","article-title":"The continuing spread of West Nile virus in the western hemisphere","volume":"45","author":"DJ Gubler","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref6","first-page":"348","article-title":"West Nile virus in Europe and Africa: still minor pathogen, or potential threat to public health","volume":"99","author":"P Couissinier-Paris","year":"2006","journal-title":"Bull Soc Pathol Exot"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1128\/JVI.01963-10","article-title":"Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas","volume":"85","author":"FJ May","year":"2011","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"M Nielsen","year":"2003","journal-title":"Protein Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"BS Davis","year":"2001","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.vetimm.2008.02.002","article-title":"A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse","volume":"123","author":"H El Garch","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2746\/042516407X217416","article-title":"Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model","volume":"39","author":"MT Long","year":"2007","journal-title":"Equine Vet J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/356152a0","article-title":"Genetic immunization is a simple method for eliciting an immune response","volume":"356","author":"DC Tang","year":"1992","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2009.02.061","article-title":"DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial","volume":"27","author":"S Jones","year":"2009","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.vaccine.2010.01.029","article-title":"Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin","volume":"28","author":"LR Smith","year":"2010","journal-title":"Vaccine"},{"key":"ref15","first-page":"1028","article-title":"Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101","volume":"8","author":"B Klencke","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.vaccine.2008.10.078","article-title":"Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6\/E7 fusion antigen","volume":"27","author":"J Yan","year":"2009","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2007.12.060","article-title":"Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers","volume":"26","author":"S Wang","year":"2008","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-2660(05)55002-8","article-title":"Human clinical trials of plasmid DNA vaccines","volume":"55","author":"MA Liu","year":"2005","journal-title":"Adv Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.gt.3300540","article-title":"A new DNA vehicle for nonviral gene delivery: supercoiled minicircle","volume":"4","author":"AM Darquet","year":"1997","journal-title":"Gene Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1089\/hum.1996.7.10-1205","article-title":"An improved plasmid DNA expression vector for direct injection into skeletal muscle","volume":"7","author":"J Hartikka","year":"1996","journal-title":"Hum Gene Ther"},{"key":"ref21","first-page":"4625","article-title":"Effect of different nuclear localization sequences on the immune responses induced by a MIDGE vector encoding bovine herpesvirus-1 glycoprotein D. Vaccine","volume":"24","author":"C Zheng","year":"2006"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4049\/jimmunol.156.1.238","article-title":"Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases","volume":"156","author":"KR Irvine","year":"1996","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00062752-199905000-00008","article-title":"Augmentation of the immune response with granulocyte-macrophage colony-stimulating factor and other hematopoietic growth factors","volume":"6","author":"H Mellstedt","year":"1999","journal-title":"Curr Opin Hematol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"326497","DOI":"10.1155\/2011\/326497","article-title":"Liposomes for use in gene delivery","volume":"2011","author":"DA Balazs","year":"2011","journal-title":"J Drug Deliv"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nano.2011.06.001","article-title":"Linear PEI nanoparticles: efficient pDNA\/siRNA carriers in vitro and in vivo","volume":"8","author":"R Goyal","year":"2012","journal-title":"Nanomedicine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1089\/aid.1997.13.1561","article-title":"An HIV type 2 DNA vaccine induces cross-reactive immune responses against HIV type 2 and SIV","volume":"13","author":"MG Agadjanyan","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.4049\/jimmunol.172.9.5561","article-title":"Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein","volume":"172","author":"R Wang","year":"2004","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1016\/j.vaccine.2011.04.116","article-title":"A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII","volume":"29","author":"A Schneeweiss","year":"2011","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.0022-202X.2004.23535.x","article-title":"DermaVir: a novel topical vaccine for HIV\/AIDS","volume":"124","author":"J Lisziewicz","year":"2005","journal-title":"J Invest Dermatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.biomaterials.2006.12.013","article-title":"Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier","volume":"28","author":"TI Kim","year":"2007","journal-title":"Biomaterials"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s11095-007-9259-7","article-title":"Engineered polyallylamine nanoparticles for efficient in vitro transfection","volume":"24","author":"A Pathak","year":"2007","journal-title":"Pharm Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejpb.2004.11.011","article-title":"Polyethylenimine-based non-viral gene delivery systems","volume":"60","author":"U Lungwitz","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijpharm.2010.03.048","article-title":"Rational development of a stable liquid formulation for nanomedicine products","volume":"392","author":"ER Toke","year":"2010","journal-title":"Int J Pharm"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1007\/s11033-009-9853-3","article-title":"Development of a targeted siRNA delivery system using FOL-PEG-PEI conjugate","volume":"37","author":"BK Biswal","year":"2010","journal-title":"Mol Biol Rep"},{"key":"ref35","first-page":"171","article-title":"Photochemical enhancement of DNA delivery by EGF receptor targeted polyplexes","volume":"434","author":"A Bonsted","year":"2008","journal-title":"Methods Mol Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1074\/jbc.274.27.19087","article-title":"Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells","volume":"274","author":"SS Diebold","year":"1999","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1022975705406","article-title":"Mannose receptor-mediated gene delivery into antigen presenting dendritic cells","volume":"27","author":"SS Diebold","year":"2002","journal-title":"Somat Cell Mol Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2005.11.014","article-title":"The mannose-binding lectin: a prototypic pattern recognition molecule","volume":"18","author":"K Takahashi","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nano.2011.07.013","article-title":"Structure and biological activity of pathogen-like synthetic nanomedicines","volume":"8","author":"O Lorincz","year":"2012","journal-title":"Nanomedicine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"11828","DOI":"10.1128\/JVI.00643-07","article-title":"Induction of epitope-specific neutralizing antibodies against West Nile virus","volume":"81","author":"T Oliphant","year":"2007","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virol.2011.01.003","article-title":"The lectin pathway of complement activation contributes to protection from West Nile virus infection","volume":"412","author":"A Fuchs","year":"2011","journal-title":"Virology"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Barzon L, Franchin E, Squarzon L, Lavezzo E, Toppo S, et al. (2009) Genome sequence analysis of the first human West Nile virus isolated in Italy in 2009. Euro Surveill 14.","DOI":"10.2807\/ese.14.44.19384-en"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e74575","DOI":"10.1371\/journal.pone.0074575","article-title":"Characterization of the mouse neuroinvasiveness of selected European strains of west nile virus","volume":"8","author":"SM Lim","year":"2013","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"T Oliphant","year":"2005","journal-title":"Nat Med"},{"key":"ref45","unstructured":"Allison; MATGWTWCRW (2012) Veterinary Hematology and Clinical Chemistry: John Wiley & Sons."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/S0264-410X(03)00141-5","article-title":"Optimization of epicutaneous immunization for the induction of CTL","volume":"21","author":"R Kahlon","year":"2003","journal-title":"Vaccine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.188.6.1075","article-title":"Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization","volume":"188","author":"A Porgador","year":"1998","journal-title":"J Exp Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1523-1747.ep12319282","article-title":"Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption","volume":"109","author":"T Nishijima","year":"1997","journal-title":"J Invest Dermatol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1128\/JVI.76.24.13097-13100.2002","article-title":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein","volume":"76","author":"DW Beasley","year":"2002","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"38755","DOI":"10.1074\/jbc.M402385200","article-title":"Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus","volume":"279","author":"DE Volk","year":"2004","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1128\/JVI.70.9.6119-6125.1996","article-title":"Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery","volume":"70","author":"TM Pertmer","year":"1996","journal-title":"J Virol"},{"key":"ref52","first-page":"1843","article-title":"Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant","volume":"8","author":"M Li","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/viro.1995.1289","article-title":"Immune responses to nucleic acid vaccines to rabies virus","volume":"209","author":"ZQ Xiang","year":"1995","journal-title":"Virology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S0022149X0999037X","article-title":"Immune responses to polyethylenimine-mannose-delivered plasmid DNA encoding a Fasciola gigantica fatty acid binding protein in mice","volume":"84","author":"S Smitha","year":"2010","journal-title":"J Helminthol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/intimm\/9.12.1897","article-title":"Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization","volume":"9","author":"JS Boyle","year":"1997","journal-title":"Int Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/icb.2011.71","article-title":"ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway","volume":"90","author":"NS Wilson","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"MS Diamond","year":"2003","journal-title":"J Virol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20031223","article-title":"A critical role for induced IgM in the protection against West Nile virus infection","volume":"198","author":"MS Diamond","year":"2003","journal-title":"J Exp Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMo020128","article-title":"West Nile virus encephalitis","volume":"347","author":"LR Petersen","year":"2002","journal-title":"N Engl J Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection","volume":"78","author":"B Shrestha","year":"2004","journal-title":"J Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/pmj.79.932.307","article-title":"Evaluation of abnormal liver function tests","volume":"79","author":"JK Limdi","year":"2003","journal-title":"Postgrad Med J"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0091631","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T07:14:12Z","timestamp":1688973252000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087837"}},"subtitle":[],"editor":[{"given":"Fausto","family":"Baldanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,4]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087837","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,4]]}}}